Printer Friendly

Browse Pharmaceutical industry topic

Research subtopic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
DaVita Clinical Research study finds mRNA COVID-19 vaccines in dialysis patients clinically effective. Report Nov 29, 2021 209
DaVita Clinical Research study finds mRNA COVID-19 vaccines in dialysis patients clinically effective. Report Nov 29, 2021 210
Study suggests people taking anti-CD20 drugs may get protection from immune system against COVID-19. Nov 25, 2021 272
Study suggest protection may last longer after COVID-19 vaccine booster dose. Nov 23, 2021 220
Study suggest protection may last longer after COVID-19 vaccine booster dose. Nov 23, 2021 219
Health Ministry: Research shows increased efficacy with Covid-19 booster shots; 825,497 already received theirs. Nov 12, 2021 428
Data from Israeli study supports efficacy of Pfizer's COVID-19 vaccine booster. Nov 2, 2021 254
Data from Israeli study supports efficacy of Pfizer's COVID-19 vaccine booster. Nov 2, 2021 253
Mixed Covid-19 booster shot strategies require more research and data, says Johor DAP leader. Oct 26, 2021 385
Philippine's vaccine mix-and-match study awaits FDA nod. Report Oct 23, 2021 477
Israeli study suggests Pfizer COVID-19 vaccine very effective against Delta variant in adolescents. Oct 21, 2021 157
Israeli study suggest Pfizer COVID-19 vaccine very effective against Delta variant in adolescents. Oct 21, 2021 156
Israeli study suggest Pfizer COVID-19 vaccine very effective against Delta variant in adolescents. Oct 21, 2021 157
Eli Lilly announces SURPASS-3 MRI sub-study achieves primary endpoint. Sep 30, 2021 250
Antibody levels reduce quickly even after 2 vaccine doses -- Swedish study. Sep 29, 2021 210
UK study to examine mixed COVID-19 vaccine dose schedules in children. Sep 17, 2021 203
UK study to examine mixed COVID-19 vaccine dose schedules in children. Sep 17, 2021 204
Scientists trialling whether children need second coronavirus vaccine; The study will include participants aged between 12 and 16 years old. By, Nina Massey & Sophie Goodall Sep 17, 2021 448
Newron Pharmaceuticals S.p.A. commences first pivotal 008A study with evenamide in patients with schizophrenia. Clinical report Sep 7, 2021 215
Specific COVID-19 antibodies found in breast milk of vaccinated women. Baulkman, Jaleesa Sep 1, 2021 600
Teens aged 12 to 15 experienced 'mild to moderate' side effects to jab, study finds; Adverse reactions were either mild or moderate in all of the 27 young people, except one who had "severe fatigue and severe discomfort combined with increased agitation". By, Aine Fox & William Walker Aug 27, 2021 623
Pfizer jab side effects on Covid vulnerable children aged 12-15 'mostly mild or moderate'; But Bristol study does not inform the debate on vaccinating healthy younger teens. By, Aine Fox, PA & David Flett & Max Channon Aug 27, 2021 652
Catching Covid increases risk of blood clots far more than vaccine; Results of largest study on vaccine side effects so far are in. By, Daniel Smith Aug 27, 2021 943
Blood clot risk from Covid 'substantially higher' than from vaccine, new study finds; For every 10 million people jabbed with AstraZeneca -66 additional cases of blood clotting in a vein were found -compared to 12,614 cases for people who had coronavirus. By, Kelly-Ann Mills Aug 27, 2021 951
Covid-19 vaccine protection waning in those first jabbed, study suggests; Protection may fall to below 50% for the elderly and healthcare workers by winter. By, Nina Massey & Kirstie McCrum Report Aug 25, 2021 587
Oxford University study shows COVID-19 vaccine efficacy declines under Delta virus variant. Aug 19, 2021 240
British study shows COVID-19 vaccine efficacy wanes under Delta. Reuters News Service Aug 19, 2021 640
Delta variant spreads among jabbed people as much as unjabbed, early research suggests; Scientists from the University of Oxford have also said their preliminary findings suggest two doses of the Pfizer/BioNTech vaccine appear to have greater effectiveness compared to the Oxford/AstraZeneca jab. By, Alahna Kindred Aug 19, 2021 739
Call for Covid booster as antibodies drop 50% within weeks of second jab; A new study of more than 5,000 people has found antibody levels dropping within six weeks of having two jabs. By, Neil Shaw Jul 23, 2021 620
Study suggests two doses of Pfizer or AstraZeneca COVID-19 vaccines effective against Delta COVID-19 variant. Jul 22, 2021 201
Study suggests two doses of Pfizer or AstraZeneca COVID-19 vaccines effective against Delta COVID-19 variant. Jul 22, 2021 200
ViiV Healthcare presents findings from CUSTOMIZE trial. Jul 18, 2021 306
AstraZeneca-jabbed up to 3 times more likely to get Covid than Pfizer, study claims; Scientists at Imperial College London have used estimates from clinical trial data, including Public Health England, to suggest the AstraZeneca jab preventing symptoms of Covid less than Pfizer. By, Ryan Merrifield Jul 16, 2021 591
Sputnik V - AstraZeneca combination study nearing completion in Azerbaijan. Jul 13, 2021 291
Singapore study shows Covid-19 mRNA vaccines are 69pc effective against Delta variant, says health minister. Jul 7, 2021 392
J&J reports positive study findings for its single dose COVID-19 vaccine against Delta variant. Jul 2, 2021 157
J&J reports positive study findings for its single dose COVID-19 vaccine against Delta variant. Jul 2, 2021 156
Regeneron says researchers find GPR75 mutations that protect against obesity. Jul 1, 2021 191
Delayed second AstraZeneca jab beneficial -- study. Jun 29, 2021 691
COVID-19 Vaccines Promise Long Lasting Immunity: Washington University Research. Bhandari, Tamara Jun 29, 2021 1120
Mixing Covid vaccines such as Pfizer and AstraZeneca gives 'robust immune response'; A new study has found that one dose of the Oxford/AstraZeneca jab and and one of the Pfizer/BioNTech jab generates a "robust immune response" against coronavirus, opening the door for more flexibility. By, Nina Massey & Dave Burke Jun 28, 2021 825
Theravance Biopharma announces nezulcitinib trial did not meet primary endpoint. Clinical report Jun 21, 2021 338
Study shows Pfizer's RA drug benefits COVID-19 patients. Jun 17, 2021 152
Study shows Pfizer's RA drug benefits COVID-19 patients. Jun 17, 2021 151
Data Published in New England Journal of Medicine Shows Pfizer's Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumonia. Jun 17, 2021 569
Vaccines key in preventing hospitalization for COVID-19 Delta variant: Study. Arab News Jun 15, 2021 284
Covid Scotland: Delta variant doubles risk of hospitalisation and vaccines less effective; The Delta variant of Covid-19 is almost twice as likely to result in hospitalisation, a ground-breaking study led by Edinburgh University has found. Elsa Maishman Jun 14, 2021 1125
Johnson & Johnson's Janssen reports MAIA and Glow study results. Jun 14, 2021 265
AstraZeneca Covid vaccine linked to small risk of blood condition; The AstraZeneca Covid-19 vaccine may be linked to a very slight increased risk of a rare blood condition, a study led by Edinburgh University has found. Elsa Maishman Jun 9, 2021 576
Novartis reports positive study results for kidney disease treatment. Jun 7, 2021 166
Merck pleased with new Keytruda study, completes Organon spinoff. Jun 4, 2021 433
Eli Lilly presents data from OVERCOME study at AHS. Jun 3, 2021 312
German scientists claim to know why AstraZeneca, Johnson & Johnson COVID-19 vaccines cause blood clots. May 28, 2021 289
Scientists 'find cause of rare blood clots linked to Covid jabs' and 'could fix it'; Concerns have been raised over possible links to rare blood clots in patients who have been given either the AstraZeneca or Johnson & Johnson vaccine. By, Deena Beasley & William Walker May 27, 2021 430
India to conduct study on effectiveness of COVID-19 vaccines of AstraZeneca and Bharat Biotech. May 26, 2021 197
India to conduct study on effectiveness of COVID-19 vaccines of AstraZeneca and Bharat Biotech. May 26, 2021 198
Study indicates that AstraZeneca/ Oxford COVID-19 vaccine works well as third booster. May 19, 2021 216
Study indicates that AstraZeneca/ Oxford COVID-19 vaccine works well as third booster. May 19, 2021 217
Spanish study finds AstraZeneca COVID-19 vaccine dose followed by Pfizer dose is safe and effective. May 18, 2021 239
Over 96% of people build antibodies after single COVID-19 jab: Study. Arab News Report May 18, 2021 383
Spanish study finds AstraZeneca COVID-19 vaccine dose followed by Pfizer dose is safe and effective. May 18, 2021 240
Pfizer, Moderna vaccines effective against Indian variants - study. Report May 17, 2021 465
Covid vaccine second dose: timing of Pfizer and AstraZeneca jabs in the UK, has it changed - and side effects; Delaying second dose of Pfizer vaccine improves immunity to fight Covid infection, research finds. Matt Brooks May 14, 2021 722
Doncaster volunteers needed for study into giving the COVID-19 and flu vaccines at the same time; Researchers at Rotherham Doncaster and South Humber NHS Foundation Trust (RDaSH), are calling for people who have had one dose of the Pfizer COVID vaccine to volunteer to take part in a study, which could set the foundations for how booster COVID-19 vaccinations are delivered in the future. Stephanie Bateman Report May 12, 2021 395
Bayer's Finerenone Meets Primary Endpoint in Phase III FIGARO-DKD Cardiovascular Outcomes Study in Patients with Chronic Kidney Disease and Type 2 Diabetes. May 10, 2021 389
Vaxart says COVID-19 vaccine study data suggests broad cross-reactivity. May 3, 2021 243
Study: Antibodies detected in 98% of vaccine recipients. May 1, 2021 635
Pfizer and Moderna vaccines appear safe, effective during pregnancy. Baulkman, Jaleesa May 1, 2021 608
Sri Lanka begins research on mixing Covid vaccines. Apr 30, 2021 308
Post-vaccine Covid infections and deaths rare, UK study says. Reuters News Service Apr 30, 2021 598
Public Health English study indicates COVID-19 vaccines cut household transmission by up to a half. Apr 28, 2021 178
Public Health English study indicates COVID-19 vaccines cut household transmission by up to a half. Apr 28, 2021 177
Single Covid vaccine dose cuts transmission by half, ground-breaking study shows; The breakthrough research offer further hope that the coronavirus pandemic can be brought under control as vaccinated people are far less likely to pass the virus onto others. By, Jane Kirby & William Walker Apr 28, 2021 646
UK study shows one dose of vaccine cuts household spread by up to 50%. Report Apr 28, 2021 310
Faulty reasoning over AstraZeneca. CM Reader's View Apr 25, 2021 168
Israeli real-world study reveals Pfizer/BioNTech COVID-19 vaccine effective for people with chronic diseases. Apr 23, 2021 179
Israeli real-world study reveals Pfizer/BioNTech COVID-19 vaccine effective for people with chronic diseases. Apr 23, 2021 180
'Possible link' found between Johnson & Johnson covid vaccine and blood clots; But research suggests blood clot risks are far higher for those catching coronavirus than it is for people who have been vaccinated. By, Max Channon Apr 20, 2021 347
Risk of rare blood clots higher for COVID-19 than for vaccines, research shows. Apr 16, 2021 240
Early studies show vaccinations mean less risk of rare blood clot. Apr 16, 2021 244
Study on the effects of mixing jabs expanded. SIMON STONE newsroom@mnamedia.co.uk Apr 14, 2021 489
Study on the effects of mixing jabs expanding. SIMON STONE newsdesk@mnamedia.co.uk Apr 14, 2021 489
Mix and match vaccine trial to expand to include Moderna and Novavax trials; Researchers have been investigating alternating doses of the Oxford/Astrazeneca and Pfizer vaccines -the first two jabs to be rolled out in the UK -since February. By, Mikey Smith & Nina Massey Apr 14, 2021 798
Mixing covid vaccines could boost immune response, animal research suggests; Combining doses of different coronavirus vaccines would give much better flexibility, say scientists. By, Max Channon Apr 14, 2021 572
Covid variant from South Africa was able to 'break through' Pfizer vaccine in Israeli study. Apr 12, 2021 609
South African variant can 'break through' Pfizer vaccine - Study. Apr 11, 2021 535
UPDATE: EMA to unveil AstraZeneca blood clot findings. Apr 7, 2021 350
Pfizer, Astrazeneca vaccines safe for the elderly: Study. Mar 30, 2021 350
Scientists find blood-clot theory for AstraZeneca vaccine recipients. Arab News Mar 30, 2021 511
Real-world study finds that shots are highly effective. MIKE STOBBE AP Medical Writer Mar 30, 2021 347
Vaccine study's positive results; 99% SHOWING ROBUST RESPONSE FROM A DOSE. MIKE KELLY Reporter mike.kelly@ncjmedia.co.uk Mar 29, 2021 401
Covid variants less resistant to vaccines, new study finds. Report Mar 19, 2021 264
All the studies say the vaccine is safe; public health chief reassures public. DANIEL HOLLAND Local Democracy Reporter daniel.holland@ncjmedia.co.uk Mar 18, 2021 571
Israeli study indicates COVID-19 vaccination of pregnant women could protect babies. Medical condition overview Mar 17, 2021 252
Israeli study indicates COVID-19 vaccination of pregnant women could protect babies. Medical condition overview Mar 17, 2021 253
Eli Lilly announces mirikizumab met primary, secondary endpoints in LUCENT-1. Clinical report Mar 16, 2021 263
Interim data from UK study indicates one dose of AstraZeneca's or Pfizer's COVID-19 vaccine reduces hospitalisation. Mar 3, 2021 264
Interim data from UK study indicates one dose of AstraZeneca's or Pfizer's COVID-19 vaccine reduces hospitalisation. Mar 3, 2021 263
Hope as DRC group shows rare HIV immune response. Mar 3, 2021 622
One Covid vaccine dose 'cuts hospital risk by 90%' -with Oxford jab 'most effective'; A new study reportedly handed to ministers using 'real world' data from the NHS coronavirus vaccine rollout has thrown up very encouraging results that one dose is cutting hospital cases by 90%. By, Jeremy Culley Feb 28, 2021 527
Unit's Covid vaccine study set to begin; COMMERCIAL FEATURE. Feb 27, 2021 610
Technology and the Healthcare Systems in Uzbekistan and Japan: a New Platform to Make a Sustainable Society with E-Healthcare by 2030. Feb 26, 2021 2439
Pfizer vaccine proven 94% effective in major study. Andrew Rosenbaum Feb 25, 2021 955
'Substantial reduction' in hospital admissions linked to vaccine rollout; New research shows the Oxford/AstraZeneca vaccine reduced the risk of hospital admission by up to 94%. By, Cathy Owen Feb 22, 2021 348
Study finds 12-week gap boosts jab effectiveness. Feb 20, 2021 163
Study in Israel indicates Pfizer/BioNTech COVID-19 vaccine 85% effective after first dose. Feb 19, 2021 191
Research data indicates delay better in administering Pfizer COVID-19 vaccine's second dose. Feb 18, 2021 377
Research data indicates delay better in administering Pfizer COVID-19 vaccine's second dose. Feb 18, 2021 381
Pfizer vaccine 'highly effective' - study. Feb 16, 2021 178
Israeli researchers state Pfizer-BioNTech COVID-19 vaccine sharply reduces symptomatic COVID-19. Feb 15, 2021 307
Israeli researchers state Pfizer-BioNTech COVID-19 vaccine sharply reduces symptomatic COVID-19. Feb 15, 2021 311
Pfizer vaccine works against COVID-19 mutations: Study. Arab News Feb 12, 2021 349
IN BRIEF: Angle Says Athens University Study Shows Value Of Parsortix. Feb 8, 2021 303
Study Shows Oxford-AstraZeneca Jab Less Effective Against SA Mutation. Feb 7, 2021 284
CELCUITY COLLABORATES WITH SARAH CANNON AND PFIZER. Feb 1, 2021 780
Study finds Pfizer/BioNTech COVID-19 vaccine only slightly less effective against key South African virus variants. Report Jan 28, 2021 256
Study finds Pfizer/BioNTech COVID-19 vaccine only slightly less effective against key South African virus variants. Report Jan 28, 2021 260
Antibody Bamlanivimab, Administered with Etesevimab Reduced Risk of COVID-19 Hospitalizations and Death by 70%, Study Shows. Clinical report Jan 26, 2021 729
Pfizer/BioNTech coronavirus vaccine effective against UK variant suggests study. Report Jan 21, 2021 332
WHO urges greater cooperation to keep pace with coronavirus mutations. Ephrem Kossaify Jan 14, 2021 661
Masks, Tests, Distancing As Effective As Vaccines On Campus: Study. Jan 14, 2021 695
Study: Masks, Distancing, Testing Shown As Effective As Vaccines on College Campuses. Andrew G. Simpson Jan 13, 2021 683
Study suggests Pfizer vaccine works against virus variant. LAURAN NEERGAARD AP Medical Writer Report Jan 9, 2021 804
New study indicates that Pfizer's COVID-19 vaccine appears to work against mutation in new virus variants. Jan 8, 2021 344
New study indicates that Pfizer's COVID-19 vaccine appears to work against mutation in new virus variants. Jan 8, 2021 340
Pfizer vaccine works against South African Covid, says study; There had been fears the mutation could be vaccine resistant. By, Neil Shaw Jan 8, 2021 204
Pfizer study suggests vaccine works against virus variant. Report Jan 8, 2021 570
Waiting 12 weeks between coronavirus vaccine doses 'will save lives', says Jonathan Van-Tam; Deputy Chief Medical Officer Jonathan Van-Tam has defended the decision to extend the time between coronavirus jabs from three weeks to 12. The leading scientist said it will allow more people to be vaccinated in a shorter time frame. By, Elaine McCahill Jan 3, 2021 645
Pectin from Okra (Abelmoschus esculentus L.) Has Potential as a Drug Release Modifier in Matrix Tablets. Boakye-Gyasi, Mariam El; Owusu, Frederick William Akuffo; Entsie, Philomena; Agbenorhevi, Jacob Kwak Jan 1, 2021 5385
'There are still obstacles to overcome in Covid fight' University scientists say people must stay vigilant despite vaccine progress. ALEX MCINTYRE cheshire.news@reachplc.com @CheshireLive Dec 31, 2020 601
Technology and the Healthcare Systems in Uzbekistan and Japan: a New Platform to Make a Sustainable Society with E-Healthcare by 2030. Dec 31, 2020 2503
UK faces Covid third wave unless vaccination target is doubled, ministers warned; The London School of Hygiene and Tropical Medicine study says the "only scenario" which can reduce the burden on hospitals is vaccinating 2 million people per week. By, Kanishka Singh & Ryan Merrifield Dec 29, 2020 400
Development, Characterization, and Pharmacological Investigation of Sesamol and Thymol Conjugates of Mefenamic Acid. Nija, B.; Rasheed, Arun; Kottaimuthu, A. Dec 28, 2020 5954
Oxford University researchers say the Oxford/ AstraZeneca COVID-19 vaccine candidate is most effective as two shots. Dec 18, 2020 318
Oxford University researchers say the Oxford/ AstraZeneca COVID-19 vaccine candidate is most effective as two shots. Dec 18, 2020 322
Scientists say Covid restrictions must last until March and vaccine may only work for nine months; England's Chief Medical Office Chris Whitty said the Pfizer vaccine might only be effective for nine months, though it could last longer. By, Martin Bagot & Dan Bloom & Hannah Graham Dec 9, 2020 451
Researchers confirm Oxford/ AstraZeneca Covid vaccine is safe and effective; Researchers have confirmed that the Oxford/ AstraZeneca Covid vaccine is safe and effective as well as providing good protection. Hannah Brown Dec 8, 2020 603
Years of research laid groundwork for speedy COVID-19 shots. LAURAN NEERGAARD AP Medical Writer Dec 8, 2020 963
Gamble pays off in 'spectacular success'. Carolyn Y. Johnson The Washington Post Dec 7, 2020 1653
AstraZeneca Says Study Shows Long-Term Efficacy Of Calquence. Dec 7, 2020 210
HAPPY accidents; MARION MCMULLEN looks at how some of the great medical breakthroughs happened by sheer chance. MARION MCMULLEN Dec 5, 2020 921
HAPPY accidents; MARION MCMULLEN looks at how some of the great medical breakthroughs happened by sheer chance. MARION MCMULLEN Dec 5, 2020 911
Top US scientist says UK has 'rushed through' vaccine approval; The European regulator has also criticised the approval of the vaccine using emergency powers, insisting that its own, slower approach is more appropriate. By, Neil Shaw Dec 4, 2020 893
Moderna vaccine confers at least 3 months immunity: study. Dec 4, 2020 422
HAPPY accidents; MARION MCMULLEN looks at how some of the great medical breakthroughs happened by sheer chance. MARION MCMULLEN Dec 3, 2020 946
HAPPY accidents; MARION MCMULLEN looks at how some of the great medical breakthroughs happened by sheer chance. MARION MCMULLEN Dec 3, 2020 921
HAPPY accidents; MARION MCMULLEN looks at how some of the great medical breakthroughs happened by sheer chance. MARION MCMULLEN Dec 2, 2020 961
HAPPY accidents; MARION MCMULLEN looks at how some of the great medical breakthroughs happened by sheer chance. MARION MCMULLEN Dec 2, 2020 945
HAPPY accidents; MARION MCMULLEN looks at how some of the great medical breakthroughs happened by sheer chance. MARION MCMULLEN Dec 2, 2020 899
Pfizer coronavirus vaccine: How does it work and why was it approved so quickly? A Covid-19 vaccine developed by Pfizer and BioNTech was developed within months using a process that usually takes years, and studies have shown it is 95% effective and works in all age groups; A Covid-19 vaccine developed by Pfizer and BioNTech was developed within months using a process that usually takes years, and studies have shown it is 95% effective and works in all age groups. By, Jane Kirby & Nina Massey & Chris Kitching Dec 2, 2020 942
HAPPY accidents; MARION MCMULLEN looks at how some of the great medical breakthroughs happened by sheer chance. MARION MCMULLEN Nov 30, 2020 933
HAPPY accidents; MARION MCMULLEN looks at how some of the great medical breakthroughs happened by sheer chance. MARION MCMULLEN Nov 30, 2020 934
HAPPY accidents; MARION MCMULLEN looks at how some of the great medical breakthroughs happened by sheer chance. MARION MCMULLEN Nov 30, 2020 961
AstraZeneca says its vaccine needs 'additional study'. Nov 27, 2020 663
AstraZeneca manufacturing error clouds Covid vaccine study results. Nov 27, 2020 816
UK mass vaccination scheme 'could be in place by summer,' SAGE scientists says; Professor Calum Semple has said there is lots to be optimistic about -but there are also potential risks and pitfalls ahead. By, Oliver Milne Nov 22, 2020 766
Baricitinib plus topical steroids reduces adult AD severity. Alexander, Walter Clinical report Nov 1, 2020 880
Baricitinib reduces atopic dermatitis severity in study. Alexander, Walter Clinical report Nov 1, 2020 780
ViiV Healthcare announces once-monthly injectable HIV treatment implementation science study positive findings. Oct 23, 2020 314
Daiichi Sankyo doses first patient in cancer drug DS-1055 study. Oct 23, 2020 194
ViiV Healthcare announces once-monthly injectable HIV treatment implementation science study positive findings. Oct 23, 2020 318
Daiichi Sankyo doses first patient in cancer drug DS-1055 study. Oct 23, 2020 198
PENELOPE-B Trial of Ibrance in Early Breast Cancer Did Not Meet Primary Endpoint. Clinical report Oct 12, 2020 426
Janssen Presents Stelara Five-Year Results from Long-term Extension Study of Clinical Response and Remission in Patients with Moderate to Severe Crohn's Disease. Clinical report Oct 12, 2020 449
Eli Lilly announces results from OVERCOME study at MTIS 2020. Clinical report Oct 9, 2020 306
Merck announces findings from Phase 3 EORTC1325/KEYNOTE-054 trial. Sep 20, 2020 164
Merck And Pfizer Report Phase III Javelin Bladder 100 Study Results. Sep 18, 2020 223
Novartis Reports Positive Results From Tafinlar Plus Mekinist Study. Sep 17, 2020 232
Shenmayizhi Formula Combined with Ginkgo Extract Tablets for the Treatment of Vascular Dementia: A Randomized, Double-Blind, Controlled Trial. Zhang, Huiqin; Cao, Yu; Pei, Hui; Wang, Huichan; Ma, Lina; Wang, Zhiyong; Diao, Xuemei; Yang, Yang; Clinical report Aug 31, 2020 6826
Nature Publishes Non-Human Primate Preclinical Viral Challenge Study of Single-shot Ad26 Vaccine that Protects Against SARS-CoV-2. Jul 31, 2020 169
Pfizer Shares Covid-19 Research Programme Data Updates. Jul 23, 2020 219
AstraZeneca/Oxford COVID data support large-scale evaluation, researchers say. Jul 20, 2020 169
Russia trying to steal COVID-19 vaccine data: Western nations. Julian E. Barnes, NYT Jul 17, 2020 1277
Eli Lilly says mirikizumab met primary, key secondary endpoints in Phase 3 study. Clinical report Jul 17, 2020 201
Pharmaceutical Giants Invest USD1 Billion In Antibiotic Research. Jul 9, 2020 294
Orthocell completes recruitment for shoulder tendon study with Johnson & Johnson subsidiary. Jul 1, 2020 380
Nigerian men are more at risk of Non-Communicable Diseases than women, study finds. Jul 1, 2020 679
BITTER PILL: We need COVID-19 treatments ASAP--but a perverse incentive could slow pharma breakthroughs. Kohrman, Nathan Jul 1, 2020 1205
Individual versus Collaborative Learning: A Strategy for Promoting Social Skills and Academic Confidence among Students. Sarwat Sultan, Irshad Hussain and Frasat Kanwal Jun 30, 2020 4171
Regeneron highlights preclinical research on CD28 costimulatory bispecifics. Jun 24, 2020 196
Brickell Biotech: All endpoints met in Phase 3 study of sofpironium bromide. Jun 15, 2020 189
Lexicon presents clinical data for Zynquista at ADA Scientific Sessions. Clinical report Jun 14, 2020 527
Novo Nordisk announces results from real-world studies of GLP-1 RAs and Ozempic. Jun 13, 2020 244
BioCryst presents findings from hereditary angioedema patient surveys. Jun 7, 2020 252
Novo Nordisk heads EU-supported international research project to improve obesity treatment and change the narrative around obesity. Jun 3, 2020 342
Novo Nordisk heads EU-supported international research project to improve obesity treatment and change the narrative around obesity. Jun 3, 2020 346
Eli Lilly doses first patients in LY-CoV555 study for COVID-19 treatment. Jun 1, 2020 230
Prediction of Drug Side Effects with a Refined Negative Sample Selection Strategy. Liang, Haiyan; Chen, Lei; Zhao, Xian; Zhang, Xiaolin May 31, 2020 8438
Merck study shows KEYTRUDA reduced risk of progression, death by 40%. May 28, 2020 248
WILLTEST SETUSFREE? Top scientist says antibody development may still not guarantee bug immunity. TORCUIL CRICHTON May 22, 2020 558
Eli Lilly announces baseline results from GERAS-US study of Alzheimer's disease. Report May 19, 2020 165
Coronavirus mutation detected by American research team. Arab News May 7, 2020 557
Regeneron, Sanofi announce first patient outside U.S. treated in Kevzara study. Mar 30, 2020 247
Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson's Disease Receiving [greater than or equal to] 2000 mg Daily Dose of Levodopa. Zadikoff, Cindy; Poewe, Werner; Boyd, James T.; Bergmann, Lars; Ijacu, Horia; Kukreja, Pavnit; Robie Clinical report Mar 1, 2020 8683
Management algorithms for metastatic prostate cancer. Malone, Shawn; Shayegan, Bobby; Basappa, Naveen S.; Chi, Kim; Conter, Henry J.; Hamilton, Robert J.; Feb 1, 2020 9046
A 12-MONTH PREP IMPLANT? New research shows that a small implant in the upper arm might be the next step in long-term HIV prevention. Dec 1, 2019 604
Health Highlights: Oct. 25, 2019; U.S. Air Quality Declines: Study J&J Baby Powder Pulled from CVS, Rite Aid and Walmart. Oct 25, 2019 289
A Framework for Comparing R&D Productivity at Big Pharma Companies vs. Biotech Startups. Murphey, Richard Oct 1, 2019 1901
The Medicines Co. announces ORION-11 study meets primary, secondary endpoints. Aug 26, 2019 338
Harvard, Merck to Collaborate on Research Led by Harvard immunologist Arlene Sharpe, seeking to Identify New Pathways for the Treatment of Cancer. Aug 13, 2019 324
Cold cures have been researched. Jul 31, 2019 176
Eli Lilly announces Phase 3 Emgality study results published. Report Jul 11, 2019 222
People pay Dh3,000 to live one year longer, study finds. Jun 29, 2019 912
Janssen Research & Development collaborates with University of California, Berkeley and the University of California, San Francisco. Jun 24, 2019 266
Janssen Research & Development collaborates with University of California, Berkeley and the University of California, San Francisco. Jun 24, 2019 262
Pfizer announces results from ORAL Shift study. Clinical report Jun 12, 2019 400
Internal docs show Pfizer chose not to pursue study of Enbrel in Alzeheimer's. Jun 4, 2019 141
India's Himalaya to open research centre at Dubai's DSP in 2021. May 14, 2019 247
Pets have a positive impact on health of owners: study. Mar 19, 2019 373
BioArctic commences phase 1 study of ABBV-0805 for Parkinson's disease. Mar 14, 2019 180
BioArctic commences phase 1 study of ABBV-0805 for Parkinson's disease. Mar 14, 2019 181
BioArctic commences phase 1 study of ABBV-0805 for Parkinson's disease. Mar 14, 2019 176
Blockade spurs pharmaceutical research in Qatar. Dec 3, 2018 446
BriaCell initiates combination study of Bria-IMT with Keytruda or Yervoy. Report Sep 26, 2018 132
An audit of clinical trials registered at clinical trial registry of India in 2017. Panchasara, Ashwin K.; Chawda, Hiren M. Report Sep 1, 2018 1495
Mallinckrodt starts lung transplant proof-of-concept study. Report Aug 2, 2018 213
Mallinckrodt starts lung transplant proof-of-concept study. Report Aug 2, 2018 209
Bristol-Myers Squibb and Tsinghua University collaborate on research into autoimmune disease and cancer treatment options. Jul 24, 2018 230
Bristol-Myers Squibb and Tsinghua University collaborate on research into autoimmune disease and cancer treatment options. Jul 24, 2018 226
Alligator Bioscience files application for clinical phase I study of ATOR-1015 in cancer patients. Jul 20, 2018 216
Alligator Bioscience files application for clinical phase I study of ATOR-1015 in cancer patients. Jul 20, 2018 217
Alligator Bioscience files application for clinical phase I study of ATOR-1015 in cancer patients. Jul 20, 2018 212
Luspatercept achieved primary and key secondary endpoints in Phase III study. Clinical report Jul 9, 2018 314
Novartis presents findings from Jakavi comparison study. Jun 15, 2018 190
Novartis presents findings from Jakavi comparison study. Jun 15, 2018 186
Checkmate-214 Study Finds Advanced RCC Patients Experience Improved Quality of Life With Opdivo Plus Low-Dose Yervoy. Clinical report Jun 5, 2018 239
Eli Lilly Phase 3 study of galcanezumab met primary endpoint. May 15, 2018 171
Eli Lilly says Phase 3 RANGE study didn't reach statistical significance for OS. Apr 20, 2018 192
Pfizer Enters TriNetX Global Health Research Network. Apr 16, 2018 289
Pfizer Enters TriNetX Global Health Research Network. Apr 13, 2018 289
MyoKardia begins patient dosing in Phase 1b clinical study of MYK-491. Feb 14, 2018 156
DOH: More studies needed to determine Sanofi liability in Dengvaxia mess. Feb 5, 2018 299
Eisai: Primary Endpoint Met in Phase II / III Clinical Study of Investigational Parkinson's Disease Treatment Safinamide in Japan. Feb 1, 2018 476
Pharmaceutical Research and Manufacturers of America. Ubl, Stephen Jan 1, 2018 520
UK's Cancer Research Technology collaborates with Celgene. Dec 19, 2017 164
UK's Cancer Research Technology collaborates with Celgene. Dec 19, 2017 160
Janssen's Phase three iNNOVATE study indicates improved progression-free survival in Waldenstrom macroglobulinemia patients. Clinical report Dec 7, 2017 184
Janssen's Phase three iNNOVATE study indicates improved progression-free survival in Waldenstrom macroglobulinemia patients. Clinical report Dec 7, 2017 180
Circassia and AstraZeneca reveal positive top-line results in Phase IV study for Tudorza. Dec 4, 2017 239
Circassia and AstraZeneca reveal positive top-line results in Phase IV study for Tudorza. Dec 4, 2017 235
Novartis reveals positive results from FLASH study investigating Ultibro Breezhaler. Nov 27, 2017 172
Novartis reveals positive results from FLASH study investigating Ultibro Breezhaler. Nov 27, 2017 168
ENDEAR Study Results of Spinraza for the Treatment of SMA Published in NEMJ. Clinical report Nov 3, 2017 212
Bayer and Janssen Research & Development halt phase III Navigate ESUS study of rivaroxaban. Oct 10, 2017 159
Lexicon Pharmaceuticals Starts Patient Dosing In A Phase 1 Study Of LX9211. Sep 28, 2017 257
Merck's anacetrapib reduces risk of major coronary events in REVEAL study. Aug 31, 2017 164
Merck's anacetrapib reduces risk of major coronary events in REVEAL study. Aug 31, 2017 160
Regeneron Study of Suptavumab for Respiratory Syncytial Virus Fails to Meet Primary Endpoint. Clinical report Aug 16, 2017 284
Samumed Completes Phase I Study of Topical Chronic Tendinopathy Treatment. Jul 24, 2017 335
Ascendis Pharma adopts global communications model with Fuze. Jun 26, 2017 278
Ascendis Pharma adopts global communications model with Fuze. Jun 26, 2017 290
Teva's Phase III study of fremanezumab sees positive results. Jun 1, 2017 218
Teva's Phase III study of fremanezumab sees positive results. Jun 1, 2017 214
Application profile of full and abbreviated dossiers for drug master file: An experience of Taiwan. Sun, I-Chen Report May 1, 2017 3029
Akcea, Ionis Announce Tout Positive Results from Study of Volanesorsen in Familial Chylomicronemia Syndrome. Clinical report Mar 7, 2017 141
Celgene Touts Study Results for Oral Otezla in Psoriasis. Mar 6, 2017 217
Lilly Touts Taltz Study Results in Moderate-to-Severe Plaque Psoriasis. Mar 6, 2017 407
NeuroVive Pharmaceutical to redirect research resources and activities of Taiwanese subsidiary to parent. Jan 26, 2017 356
NeuroVive Pharmaceutical to redirect research resources and activities of Taiwanese subsidiary to parent. Jan 26, 2017 352
NeuroVive Redirects Research Resources from Taiwan Unit to Parent. Jan 26, 2017 322
NeuroVive Redirects Research Resources from Taiwan Unit to Parent. Jan 26, 2017 331
Pfizer collaborates with IBM for immuno-oncology research. Dec 5, 2016 170
Pfizer collaborates with IBM for immuno-oncology research. Dec 5, 2016 166
Oncodesign Closes Acquisition of GSK's Research Centre in France. Dec 1, 2016 206
Oncodesign Closes Acquisition of GSK's Research Centre in France. Dec 1, 2016 216
Preliminary Phase Ib Clinical Study Results for Lenvatinib in Combination with Pembrolizumab in Selected Solid Tumors Presented at ESMO 2016. Clinical report Oct 12, 2016 1082
Initiatives propel nanomedicine's growth. Nelson, Rick Report Jan 1, 2016 841
Joint Japanese program for iPS cell application research. Dec 21, 2015 221
Joint Japanese program for iPS cell applications research. Dec 15, 2015 224
Joint Japanese program for iPS cell applications research. Dec 14, 2015 224
Bristol-Myers Squibb establishes new research with Princeton University. Dec 10, 2015 165
Bristol-Myers Squibb establishes new research with Princeton University. Dec 10, 2015 161
Turing Pharmaceuticals commences dosing first group of patients in TUR-004 single ascending dose study. Nov 18, 2015 145
Turing Pharmaceuticals commences dosing first group of patients in TUR-004 single ascending dose study. Nov 18, 2015 141
UNESCO and Merck collaborate on Africa research capacity. Oct 21, 2015 219
UNESCO and Merck collaborate on Africa research capacity. Oct 21, 2015 215
Off-label on the table. Pitts, Peter J. Column Jul 1, 2015 3164
EISAI to introduce new research on Halaven(R) and Lenvima(R) at 51st ASCO Annual Meeting. May 15, 2015 248
EISAI to introduce new research on Halaven(R) and Lenvima(R) at 51st ASCO Annual Meeting. May 15, 2015 244
Creating a culture of productivity and collaborative innovation: Orion's R&D Transformation: faced with the need to improve productivity, Orion's R&D group built a new culture of productivity and collaborative innovation through incremental initiatives and a comprehensive reorganization. Thong, Robert; Lotta, Timo May 1, 2015 7464
Postive Results Published on Actavis, Medicines360 Study on Intrauterine System. Apr 28, 2015 482
CiRA, Takeda to collaborate on iPS Cell Research. Apr 20, 2015 200
CiRA, Takeda to collaborate on iPS cell research. Apr 20, 2015 199
KaloBios Pharmaceuticals receives top-line data from Phase II study of KB001-A. Clinical report Jan 8, 2015 163
KaloBios Pharmaceuticals receives top-line data from Phase II study of KB001-A. Clinical report Jan 8, 2015 159
Pharmaceutical Research and Manufacturers of America (PhRMA). Castellani, John Jan 5, 2015 1313
Dynavax to advance TLR9 Agonist into Phase 2a asthama clinical study in partnership with AstraZeneca. Clinical report Dec 9, 2014 240
Dynavax to advance TLR9 Agonist into Phase 2a asthama clinical study in partnership with AstraZeneca. Clinical report Dec 9, 2014 236
Isis Pharmaceuticals earns USD18m for the development of its ISIS-TTR Rx double-blind, placebo-controlled, international study in FAP patients. Clinical report Oct 9, 2014 177
Study shows superiority of Dako's HER2 IQFISH pharmDx kit over Abbott's PathVysion HER-2 DNA Probe kit. Jul 8, 2014 290
Shining light on madness. Rotman, David Jul 1, 2014 4348
Pfizer reveals results from Oral treatment Psoriasis Trial Retreatment study. May 27, 2014 168
Pfizer reveals results from Oral treatment Psoriasis Trial Retreatment study. May 27, 2014 164
The impact of pharmaceutical promotions on primary health care physicians' prescribing behaviour in KAMC in central region. Zahrani, Hayat Saleh Al Report Mar 1, 2014 5119
Adherence is a priority for suppliers. Jan 6, 2014 354
Genzyme reports positive data from TOPIC study of Aubagio. Oct 3, 2013 274
Genzyme reports positive data from TOPIC study of Aubagio. Oct 3, 2013 270
A role for virtual biotechnology companies in drug discovery and development? Nicol, Dianne; Liddicoat, Johnathon; Critchley, Christine Statistical data Jul 1, 2013 5880
Joint study on human skin cells yields promising results. Mar 25, 2013 303
Joint study on human skin cells yields promising results. Mar 25, 2013 303

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |